GENB · Generate Biomedicines, Inc. · Off Exchange
$9.54
-0.83 (-8.00%)
At close · Nov 20
Return incl. dividend (before tax)
Going-concern doubt
— cleared Nov 12, 2026
The latest filing states the doubt was alleviated.
“As of December 31, 2025, the Company had concluded that there was substantial doubt about its ability to continue as a going concern. Upon closing of the IPO and receipt of the associated cash proceeds, the Company has alleviated the substantial doubt that previously existed, and based on the Company’s current capital resources, which consist of its cash, cash equivalents and marketable securities on hand at September 30, 2026, together with the $30.0 million upfront payment received from Zealand in October 2026 in connection with the Zealand collaboration, it expects to have sufficient cash to fund its current operating plan into the first half of 2028.”View the 10-Q filed Nov 12, 2026
Market Cap
$1.23B
Shares
129.10M
Volume · Nov 20
967.86K
Avg daily vol (3M)
1.23M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-10-12 | 1,821,753 | 744,900 | 2,566,653 | 45.5% |
| 2026-10-05 | 1,230,558 | 1,116,843 | 2,347,401 | 44.5% |
| 2026-09-28 | 1,376,755 | 781,835 | 2,158,590 | 42.1% |
| 2026-09-21 | 1,914,162 | 987,623 | 2,901,785 | 42.5% |
| 2026-09-14 | 1,996,570 | 1,385,080 | 3,381,650 | 44.4% |
| 2026-09-07 | 1,170,256 | 661,848 | 1,832,104 | 46.8% |
| 2026-08-31 | 1,518,798 | 886,009 | 2,404,807 | 46.4% |
| 2026-08-24 | 5,191,087 | 3,236,049 | 8,427,136 | 51.8% |
| 2026-08-17 | 1,536,898 | 740,336 | 2,277,234 | 50.6% |
| 2026-08-10 | 798,002 | 280,013 | 1,078,015 | 42.6% |
| 2026-08-03 | 632,879 | 289,902 | 922,781 | 38.9% |
| 2026-07-27 | 843,666 | 472,180 | 1,315,846 | 41.5% |
| 2026-07-20 | 487,463 | 228,085 | 715,548 | 38.1% |
| 2026-07-13 | 562,780 | 324,581 | 887,361 | 38.1% |
| 2026-07-06 | 1,355,984 | 643,384 | 1,999,368 | 48.1% |
| 2026-06-29 | 1,252,838 | 1,047,893 | 2,300,731 | 47.6% |
| 2026-06-22 | 1,270,209 | 1,533,533 | 2,803,742 | 36.4% |
| 2026-06-15 | 622,127 | 1,284,887 | 1,907,014 | 40.9% |
| 2026-06-08 | 664,899 | 451,723 | 1,116,622 | 37.0% |
| 2026-06-01 | 1,704,598 | 1,570,423 | 3,275,021 | 48.1% |
| 2026-05-25 | 696,163 | 545,184 | 1,241,347 | 49.0% |
| 2026-05-18 | 1,395,731 | 1,111,820 | 2,507,551 | 48.8% |
| 2026-05-11 | 703,051 | 558,040 | 1,261,091 | 43.4% |
| 2026-05-04 | 488,112 | 161,709 | 649,821 | 45.0% |
| 2026-04-27 | 487,563 | 76,018 | 563,581 | 43.8% |
| 2026-04-20 | 579,246 | 317,473 | 896,719 | 44.8% |
| 2026-04-13 | 493,578 | 388,695 | 882,273 | 51.4% |
| 2026-04-06 | 440,834 | 219,864 | 660,698 | 42.3% |
| 2026-03-30 | 329,204 | 264,013 | 593,217 | 42.0% |
| 2026-03-23 | 391,648 | 284,456 | 676,104 | 34.5% |
| 2026-03-16 | 317,653 | 221,112 | 538,765 | 28.2% |
| 2026-03-09 | 1,168,296 | 407,127 | 1,575,423 | 39.9% |
| 2026-03-02 | 1,547,478 | 651,524 | 2,199,002 | 39.4% |
| 2026-02-23 | 1,434,218 | 713,802 | 2,148,020 | 34.5% |
Showing 1–34 of 34 weeks
Key facts
CIK
2100782
CUSIP
370920100
13F (30d)
100 filings
98 filers
Visit website
Investor relations